LOGIN
AAOS 2024: One- Vs Two-Stage Treatment for Periprosthetic Joint Infection: Interim Results
February 2024
AAOS 2024: One- Vs Two-Stage Treatment for Periprosthetic Joint Infection: Interim Results
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
One-stage versus two-stage treatment for prosthetic joint infection: a prospective, randomized clinical trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
321 patients with chronically infected hip and knee arthroplasties were randomized to receive either a one-stage (n=164) or two-stage treatment (n=157). Outcomes of interest included a one-year success rate, relative risk of failure, and adverse events. Interim results indicated that adverse events, one-year success rate, and relative risk were similar between the two groups.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.